A Quebec clinical perspective of the randomized clinical trial SWOG S1007 (RxPonder)

Expected medium- and long-term impact of the COVID-19 on Breast Cancer Treatment in Quebec

SABCS 2020 - Circulating Tumor Cell Dynamics May Predict Treatment Response and Prognosis

SABCS 2020 - First results from a phase III randomized clinical trial SWOG S1007 (RxPonder)

SABCS 2020 - 21-Gene Breast Recurrence Score® impact upon physician treatment decision in Quebec